Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 5:18 PM
Ignite Modification Date:
2025-12-26 @ 5:18 PM
NCT ID:
NCT00132106
Eligibility Criteria:
Inclusion Criteria:
* Heart failure of at least New York Heart Association (NYHA) class II
* Left ventricular ejection fraction (LVEF) \<= 40%
* Age 18-75 years
Exclusion Criteria:
* Alfa-blockers, or beta-blockers with alfa-blocking activity (carvedilol)
* Tricyclic antidepressants
* Warfarin derivatives (acetylic salicylic acid and clopidogrel are allowed)
* Hospitalisation in 6 weeks prior to the study
* Any change in medication in 6 weeks prior to the study
* Unstable angina
* Orthopnoea
* Known chronic disease of the autonomic nervous system
* Diabetes mellitus
* Oedema of the lower extremities, complicating the insertion of a venous catheter in a vein on the foot
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00132106
Study Brief:
Protocol Section:
NCT00132106